Actinium Pharmaceuticals
ATNM
#9862
Rank
S$56.63 M
Marketcap
S$1.82
Share price
-2.10%
Change (1 day)
2.55%
Change (1 year)

Actinium Pharmaceuticals (ATNM) - Cash on Hand

Cash on Hand as of June 2025 : S$77.71 Million

According to Actinium Pharmaceuticals's latest financial reports the company has S$77.71 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Actinium Pharmaceuticals - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$99.09 M-2.14%
2023-12-31S$0.10 B-30.64%
2022-12-31S$0.14 B38.76%
2021-12-31S$0.10 B25.13%
2020-12-31S$84.08 M573.98%
2019-12-31S$12.47 M-33.21%
2018-12-31S$18.67 M-19.73%
2017-12-31S$23.27 M-21.64%
2016-12-31S$29.69 M-18.13%
2015-12-31S$36.27 M308.62%
2014-12-31S$8.87 M26.49%
2013-12-31S$7.01 M2.14%
2012-12-31S$6.87 M-6.98%
2011-12-31S$7.38 M3822889.28%
2010-12-31S$0 M-93.51%
2009-12-31S$0 M-6.08%
2008-12-31S$0 M-4.74%
2007-12-31S$0 M366%
2006-12-31S$0 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Genocea Biosciences
GNCA
S$26.11 M-66.40%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$1.91 B 2,366.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$0.34 B 340.27%๐Ÿ‡บ๐Ÿ‡ธ USA